CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-200413, 333-203032, 333-210058, 333-216432, 333-232428, 333-237380, 333-255173 and 333-273900 on Form S-8 and

Registration Statement Nos. 333-254890, 333-272052, 333-279711 and 333-282260 on Form S-3 of our report dated March 19, 2026, relating to the financial statements of Eledon Pharmaceuticals, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2025.

/s/ Deloitte & Touche LLP

Costa Mesa, California

March 19, 2026